// App-Quantinova.ai

: GENE-34. THERAPEUTICALLY TARGETING EPIGENOMIC AND TRANSCRIPTIONAL DYSFUNCTION IN ATRX-DEFICIENT GLIOMA

Researchers

Presenter

  • Carla Danussi

Principal Investigators

  • Anand Singh

  • Pavan Pinnamaneni

  • Grant Fisher

  • David Picketts

  • Kasthuri Kannan

  • Arvind Rao

  • Kunal Rai

  • Jason Huse

Medical Centers

  • 1.MD Anderson Cancer Center, Houston, TX

  • The Ottawa Hospital Research Institute, Ottawa, ON, Canada

Locations

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Oncology (ONC)

Disease

  • Gliomas

  • ATRX syndrome

Biomarkers

  • Trimethylation of lysine 27 on histone H3

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved